XML 71 R7.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Operating Activities    
Net income $ 80,474 $ 69,355
Adjustments to reconcile net income to net cash flows provided by operating activities:    
Depreciation, amortization and accretion 21,871 16,290
Provision for credit losses 17,000 17,411
Deferred tax expense (benefit) 5,789 (2,454)
Net securities gains (5) (10,237)
Tax benefit of stock-based compensation (192) (1,505)
Loans originated for sale (195,538) (51,761)
Loans sold 198,787 58,659
Gain on sale of loans (3,780) (2,465)
Net change in:    
Interest receivable (1,593) 40
Interest payable (492) (1,292)
Securities classified as trading in business combination and sold   203,178
Bank owned life insurance (2,524) (3,375)
Other, net (14,562) 8,705
Net cash flows provided by operating activities 105,235 300,549
Investing Activities    
Net change in loans and leases (402,216) (538,144)
Securities available for sale:    
Purchases (242,375) (526,470)
Sales 33,228 150,055
Maturities 125,270 172,295
Securities held to maturity:    
Purchases (204,591) (325,989)
Maturities 137,518 95,152
Purchase of bank owned life insurance (24) (4,448)
Withdrawal/surrender of bank owned life insurance   715
Increase in premises and equipment (8,651) (8,021)
Net cash received in business combinations   27,058
Net cash flows used in investing activities (561,841) (957,797)
Financing Activities    
Demand (non-interest bearing and interest bearing) and savings accounts 999,376 451,460
Time deposits (21,510) (122,075)
Short-term borrowings (534,076) 263,271
Increase in long-term borrowings 14,654 216,736
Decrease in long-term borrowings (13,544) (58,831)
Net proceeds from issuance of common stock 7,772 6,376
Tax benefit of stock-based compensation 192 1,505
Cash dividends paid:    
Preferred stock (4,020) (4,332)
Common stock (42,152) (40,123)
Net cash flows provided by financing activities 406,692 713,987
Net (Decrease) Increase in Cash and Cash Equivalents (49,914) 56,739
Cash and cash equivalents at beginning of period 287,393 213,981
Cash and Cash Equivalents at End of Period $ 237,479 $ 270,720